Allarity Therapeutics, Inc.
ALLR
$1.61
-$0.15-8.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.32M | -2.73M | -7.45M | -11.59M | -1.63M |
| Total Depreciation and Amortization | 12.00K | 11.00K | 1.00K | 5.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.00K | 184.00K | 340.00K | 9.30M | -2.09M |
| Change in Net Operating Assets | -3.42M | -149.00K | 3.91M | -3.16M | -3.59M |
| Cash from Operations | -5.48M | -2.69M | -3.21M | -5.44M | -7.30M |
| Capital Expenditure | -- | -- | -298.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -298.00K | -- | -- |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -1.34M |
| Issuance of Common Stock | 0.00 | 11.14M | 4.24M | 5.43M | 27.65M |
| Repurchase of Common Stock | -2.57M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 2.94M | -- |
| Repurchase of Preferred Stock | -- | -- | 0.00 | -3.50M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.57M | 11.14M | 4.24M | 4.87M | 26.31M |
| Foreign Exchange rate Adjustments | -1.86M | -286.00K | 339.00K | -195.00K | -84.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.90M | 8.17M | 1.07M | -770.00K | 18.92M |